The future of technologies for personalised medicine.

[1]  S. Hogarth.  Regulatory experiments and transnational networks: the governance of pharmacogenomics in Europe and the United States , 2012 .

[2]  Z. Popovic,et al.  Crystal structure of a monomeric retroviral protease solved by protein folding game players , 2011, Nature Structural &Molecular Biology.

[3]  W. Newman,et al.  Pharmacogenetics and pharmacogenomics: a clinical reality , 2011, Annals of clinical biochemistry.

[4]  Angela Brand,et al.  Health Literacy and Public Health Genomics: Innovation Management by Citizens , 2011, Public Health Genomics.

[5]  Nicholas Eriksson,et al.  Efficient Replication of over 180 Genetic Associations with Self-Reported Medical Data , 2011, PloS one.

[6]  B. Prainsack,et al.  Voting with their Mice: Personal Genome Testing and the “Participatory Turn” in Disease Research , 2011, Accountability in research.

[7]  M. Massagli,et al.  Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm , 2011, Nature Biotechnology.

[8]  M. Guyer,et al.  Charting a course for genomic medicine from base pairs to bedside , 2011, Nature.

[9]  A. Brand.  Public health genomics--public health goes personalized? , 2011, European journal of public health.

[10]  Aaron Panofsky.  Generating sociability to drive science: Patient advocacy organizations and genetics research , 2011, Social studies of science.

[11]  J. Stockman.  Disclosure of APOE Genotype for Risk of Alzheimer's Disease , 2011 .

[12]  B. Prainsack,et al.  Solidarity. Reflections on an Emerging Concept in Bioethics. Summary , 2011 .

[13]  O. Mekel,et al.  The Contribution of Health Technology Assessment, Health Needs Assessment, and Health Impact Assessment to the Assessment and Translation of Technologies in the Field of Public Health Genomics , 2010, Public Health Genomics.

[14]  Jane Calvert,et al.  Systems biology, interdisciplinarity and disciplinary identity , 2010 .

[15]  Gregory Nuel,et al.  Deciphering Normal Blood Gene Expression Variation—The NOWAC Postgenome Study , 2010, PLoS genetics.

[16]  Jamie Lewis.  Matchmaking mechanisms: collaborative arrangements in proteomics and bioinformatics , 2010 .

[17]  Garage biology , 2010, Nature.

[18]  H. Willard,et al.  Genomic and personalized medicine: foundations and applications. , 2009, Translational research : the journal of laboratory and clinical medicine.

[19]  A. Brand,et al.  The EU FP6 EpiGenChlamydia Consortium: contribution of molecular epidemiology and host-pathogen genomics to understanding Chlamydia trachomatis-related disease. , 2009, Drugs of today.

[20]  J. Witte,et al.  The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop , 2009, Genetics in Medicine.

[21]  David J. Galas,et al.  Systems Biology and Emerging Technologies Will Catalyze the Transition from Reactive Medicine to Predictive, Personalized, Preventive and Participatory (P4) Medicine , 2009 .

[22]  Barbara Prainsack,et al.  Personal genomes: Misdirected precaution , 2008, Nature.

[23]  Patrick L. Taylor.  Personal Genomes: When consent gets in the way , 2008, Nature.

[24]  A. Miles,et al.  Evidence-based healthcare, clinical knowledge and the rise of personalised medicine. , 2008, Journal of evaluation in clinical practice.

[25]  E. Abrahams.  Right Drug—Right Patient—Right Time: Personalized Medicine Coalition , 2008, Clinical and translational science.

[26]  Gabriele Siciliano,et al.  Lithium delays progression of amyotrophic lateral sclerosis , 2008, Proceedings of the National Academy of Sciences.

[27]  J. Hesketh,et al.  Nutrigenomic approaches for benefit-risk analysis of foods and food components: defining markers of health , 2007, British Journal of Nutrition.

[28]  H. Kitano.  Towards a theory of biological robustness , 2007, Molecular systems biology.

[29]  S. Archer.  The making of a physician-scientist--the process has a pattern: lessons from the lives of Nobel laureates in medicine and physiology. , 2007, European heart journal.

[30]  Mike Michael,et al.  From bench to bedside? Biomedical scientists' expectations of stem cell science as a future therapy for diabetes. , 2006, Social science & medicine.

[31]  C. Novas.  The Political Economy of Hope: Patients’ Organizations, Science and Biovalue , 2006 .

[32]  J. Eady,et al.  Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. , 2005, Physiological genomics.

[33]  Hiroaki Kitano,et al.  Biological robustness , 2008, Nature Reviews Genetics.

[34]  Michael E Phelps,et al.  Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.

[35]  J. Stelling,et al.  Robustness of Cellular Functions , 2004, Cell.

[36]  A. Rosoff.  THE GOLD STANDARD: THE CHALLENGE OF EVIDENCE-BASED MEDICINE AND STANDARDIZATION IN HEALTH CARE , 2004 .

[37]  A. Hedgecoe,et al.  The Politics of Personalised Medicine: Pharmacogenetics in the Clinic , 2004 .

[38]  D. Wanless.  Securing Good Health for the Whole Population , 2004 .

[39]  T. Osborne.  Against ‘creativity’: a philistine rant , 2003 .

[40]  W. Pardridge,et al.  Translational science: what is it and why is it so important? , 2003, Drug discovery today.

[41]  F. Marincola.  Translational Medicine: A two-way road , 2003, Journal of Translational Medicine.

[42]  S. Timmermanns,et al.  The Challenge of Evidence-Based Medicine and Standardization in Health Care , 2003 .

[43]  R. Sartor.  Translational research: Bridging the widening gap between basic and clinical research. , 2003, Gastroenterology.

[44]  Ash A. Alizadeh,et al.  Individuality and variation in gene expression patterns in human blood , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  T. Carrel.  The relationship between surgeon and basic scientist. , 2002, Transplant immunology.

[46]  Hiroaki Kitano,et al.  Looking beyond the details: a rise in system-oriented approaches in genetics and molecular biology , 2002, Current Genetics.

[47]  M. Callon,et al.  The involvement of patients' associations in research , 2002 .

[48]  John Doyle,et al.  Complexity and robustness , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Sui Huang,et al.  The practical problems of post-genomic biology , 2000, Nature Biotechnology.

[50]  C. Sander,et al.  Genomic medicine and the future of health care. , 2000, Science.

[51]  Complicated is not complex , 1999, Nature Biotechnology.

[52]  D L Sackett,et al.  Evidence-based medicine. , 1997, Seminars in perinatology.

[53]  M Berg,et al.  Turning a Practice into a Science: Reconceptualizing Postwar Medical Practice , 1995, Social studies of science.

[54]  I. Illich.  Limits to Medicine: Medical Nemesis - The Expropriation of Health , 1991 .

[55]  Ivan Illich,et al.  Limits to medicine , 1976 .